The Medicines Company (6)
Browse by Contract Category
Contracts
-
Supplemental Indenture, dated as of January 6, 2020, to the indenture, dated as of January 13, 2015, between the Company and the Trustee
(Filed With SEC on January 6, 2020)
-
Agreement and Plan of Merger, dated as of November 23, 2019, by and among The Medicines Company, Novartis AG and Medusa Merger Corporation
(Filed With SEC on November 25, 2019)
-
Separation Agreement, dated March 15, 2019, between Christopher Cox and the registrant
(Filed With SEC on April 26, 2019)
-
Supplemental Indenture, dated as of January 6, 2020, to the indenture, dated as of June 10, 2016, between the Company and the Trustee
(Filed With SEC on January 6, 2020)
-
Supplemental Indenture, dated as of January 6, 2020, to the indenture, dated as of December 18, 2018, between the Company and the Trustee
(Filed With SEC on January 6, 2020)
-
Underwriting Agreement, dated as of June 25, 2019, by and among the Company, Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC
(Filed With SEC on June 28, 2019)
